TABLE 1

Baseline Demographic Data

TreatmentPlacebo
All patients
    Sample size, N1516
    Age, y
        Range2.1–17.30.7–15.7
        Mean ± SD8.0 ± 5.06.3 ± 4.5
        Median7.35.2
    Gender, n
        Female88
        Male78
    EASI score, mean ± SD22.1 ± 13.316.6 ± 9.8
    IGA score, mean ± SD3.67 ± 0.823.50 ± 0.63
    Proportion of BSA affected, mean ± SD, %37.8 ± 21.628.1 ± 18.2
Patients treated for ≥1 moa
    Sample size, N1114
    Age, y
        Range2.1–17.30.7–15.7
        Mean ± SD8.2 ± 5.76.3 ± 4.8
        Median7.54.6
    EASI score, mean ± SD26.9 ± 8.217.7 ± 9.9
    IGA score, mean ± SD3.82 ± 0.873.50 ± 0.65
    Proportion of BSA affected, mean ± SD44.6 ± 20.829.1 ± 18.5
  • a Patients who completed only the baseline visit were excluded.